High Throughput Screening (HTS) Market Report 2026

High Throughput Screening (HTS) Market Overview

• High Throughput Screening (HTS) market size has reached to $25.26 billion in 2025 • Expected to grow to $38.34 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Growing Prevalence Of Chronic Diseases Fuels High-Throughput Screening Market Expansion • Market Trend: Innovative Multimode Plate Reader Revolutionizes High Throughput Screening Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under High Throughput Screening (HTS) Market?

High-throughput screening (HTS) is a technique employed in drug discovery and various scientific domains to rapidly assess a large number of samples for biological activity. Its purpose is to identify active compounds, antibodies, or genes that modulate specific biological pathways, thereby expediting the drug discovery process. The main types of products and services in high-throughput screening (HTS) are consumables and reagents, instruments, software, and services. Consumables and reagents refer to the materials and chemicals used in the screening process, including sample containers, assay reagents, and other disposable items necessary for experimental procedures. The technology types are categorized into ultra-high-throughput screening, cell-based assays, lab-on-a-chip, and label-free technology, which are used in several applications such as target identification and validation, primary and secondary screening, toxicology assessment, and others. The end users include the pharmaceutical and biotechnology industries, academic and research institutes, contract research organizations, and others.

What Is The High Throughput Screening (HTS) Market Growth Forecast?

The high throughput screening (hts) market size is expected to see strong growth in the next few years. It will grow to $38.34 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to integration of ai and machine learning in hts, growth of personalized medicine, rising investments in biotechnology startups, expansion of emerging markets in asia-pacific, development of multiplexed and label-free assay technologies. Major trends in the forecast period include high-throughput automation integration, miniaturization of screening platforms, advanced detection technologies, multiplexed assay development, cloud-based data management.

Global High Throughput Screening (HTS) Market Segmentation

1) By Products And Services: Consumables And Reagents, Instruments, Software And Services 2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology 3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications 4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users Subsegments: 1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents 2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices 3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

What Is The Driver Of The High Throughput Screening (HTS) Market?

The rise in the prevalence of chronic diseases is expected to propel the growth of the high-throughput screening (HTS) market going forward. Chronic disease refers to a long-term health condition or disease that persists over an extended period, typically lasting for three months or more. HTS enables rapid screening of numerous chemical compounds to pinpoint potential drug candidates targeting specific pathways or mechanisms implicated in chronic diseases, essential for their effective long-term management. For instance, in January 2023, according to the National Library of Medicine, a US-based government agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Therefore, the rise in the prevalence of chronic diseases will drive the growth of the high-throughput screening (HTS) market.

Key Players In The Global High Throughput Screening (HTS) Market

Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.

Global High Throughput Screening (HTS) Market Trends and Insights

Major companies operating in the high-throughput screening market are developing innovative products, such as multimode plate readers, to better serve their customers with advanced features. A multimode plate reader (MPR) is an advanced lab tool used in high-throughput screening, analyzing biological and chemical samples in microplates by integrating multiple detection modes for diverse assays within a single platform. For instance, in February 2023, PerkinElmer Inc., a US-based MedTech company, launched the EnVision Nexus system. The EnVision Nexus system stands out as the fastest and most sensitive multimode plate reader available, explicitly designed for demanding high-throughput screening (HTS) applications to expedite drug discovery efforts. With its unique technology, including dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, coupled with the latest reagent kits, the platform offers researchers unparalleled assay flexibility, accuracy, speed, and sensitivity. Equipped with walkaway convenience options such as a plate stacker for 20 or 50 plates or full automation and integration for continuous 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with unprecedented efficiency.

What Are Latest Mergers And Acquisitions In The High Throughput Screening (HTS) Market?

In December 2023, PerkinElmer Inc., a US-based MedTech company, acquired Covaris Inc. for an undisclosed amount. With this acquisition, Covaris' growth potential is anticipated to be accelerated, while PerkinElmer's existing life sciences portfolio is poised to expand into the rapidly growing diagnostics end market. Covaris Inc. is a US-based provider of high-throughput screening solutions.

Regional Insights

North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the High Throughput Screening (HTS) Market?

The high-throughput screening (HTS) market consists of revenues earned by entities by providing services such as compound library screening, assay design and adaptation, and pilot screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-throughput screening (HTS) market also includes sales of lab equipment and supplies, chemicals, assay development tools, and data processing software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the High Throughput Screening (HTS) Market Report 2026?

The high throughput screening (hts) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the high throughput screening (hts) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.